STAT3 determines IL-4 signalling outcomes in naïve T cells.
Saved in:
| Title: | STAT3 determines IL-4 signalling outcomes in naïve T cells. |
|---|---|
| Authors: | Deimel LP; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.; Sir William Dunn School of Pathology, Medical Sciences Division, University of Oxford, Oxfordshire, OX1 3RE, UK., Li Z; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Roy S; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA., Ranasinghe C; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia. charani.ranasinghe@anu.edu.au. |
| Source: | Scientific reports [Sci Rep] 2021 May 18; Vol. 11 (1), pp. 10495. Date of Electronic Publication: 2021 May 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-021-89860-7 |
